Biomaterials in drug delivery and tissue engineering: One laboratory's experience

Accounts of Chemical Research

Volumn 33, Issue 2, 2000, Pages 94-101

  Langer, Robert ^a  

^a Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CARMUSTINE; CATALASE; DICHLOROMETHANE; ETHYLENE VINYL ACETATE COPOLYMER; GONADORELIN; HUMAN GROWTH HORMONE; LYSOZYME; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; SEBACIC ACID;

AEROSOL; ANIMAL; ARTICLE; ARTIFICIAL ORGAN; BIOENGINEERING; BIOMEDICAL ENGINEERING; CASE REPORT; CELL TRANSPLANTATION; CHEMISTRY; CHILD; DRUG DELIVERY SYSTEM; DRUG RELEASE; GENETIC ENGINEERING; GENETIC PROCEDURES; HUMAN; INHALATION; MAGNETISM; MALE; PROTEIN SECRETION; ULTRASOUND THERAPY; XENOGRAFT;

ANIMALS; ARTIFICIAL ORGANS; BIOCOMPATIBLE MATERIALS; BIOMEDICAL ENGINEERING; BIOSENSING TECHNIQUES; DRUG DELIVERY SYSTEMS; HUMANS;

EID: 0033956526     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar9800993     Document Type: Article

References (71)

1. Ratner, B. D.; Hoffman, A. S.; Schoen, F. J.; Lemons, J. An introduction to materials in medicine. Biomaterials Science; Academic Press: San Diego, CA, 1996; pp 1-469.
2. Lanza, R. P.; Langer, R.; Chick, W. L. Principles of Tissue Engineering; Academic Press: Austin, TX, 1997; pp 405-427.
3. Ron, E.; Langer, R. Erodible Sytems. In Treatise on Controlled Drug Delivery; Kydonieus, A., Ed.; Marcel Dekker: New York 1992; pp 199-221.
4. Mooney, D. J.; Mikos, A. G. Growing new organs. Sci. Am. 1999, 240 (4), 60-65.
5. Langer, R. Drug delivery and targeting, Nature 1998, 392 (Suppl.), 5-10.
6. Langer, R.; Brem, H.; Falterman, K.; Klein, M.; Folkman, J. Isolation of a cartilage factor that inhibits tumor neovascularization. Science 1976, 193, 70-72.
7. Langer, R. Bioavailability of macromolecular drugs and its control in controlled drug bioavailability. In Bioavailability Control by Drug Delivery System Design; Smolen, V., Ed.; J. Wiley and Sons: New York, 1985; Vol. 3, pp 307-362.
8. Ball, P. Spare parts: biomedical materials. Made to Measure: New Materials for the 21st Century; Princeton University Press: Princeton, NJ, 1997; p 240.
9. Langer, R.; Folkman, J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976, 263, 797-800.
10. Cohen, S.; Yoshioka, T.; Lucarelli, M.; Hwang, L. H.; Langer, R. Controlled delivery systems for proteins based on poly(lactic/ glycolic acid) microspheres. Pharm. Res. 1991, 8, 713-720.
11. Hsieh, D.; Rhine, W.; Langer, R. Zero-order controlled release polymer matrices for micromolecules and macromolecules. J. Pharm. Sci. 1983, 72, 17-22.
12. Bawa, R.; Siegel, R.; Marasca, B.; Karel, M.; Langer, R. An explanation for the sustained release of macromolecules from polymers. J. Controlled Release 1985, 1, 259-267.
13. Hsu, T.; Langer, R. Polymers for the controlled release of macromolecules: Eeffect of molecular weight of ethylene-vinyl acetate copolymer. J. Biomed. Mater. Res. 1985, 19, 445-460.
14. Rhine, W.; Hsieh, D. S. T.; Langer, R. Polymers for sustained macromolecules release: procedures to fabricate reproducible delivery systems and control release kinetics. J. Pharm. Sci. 1980, 69, 265-270.
15. Ogawa, Y.; Yamamoto, M.; Okada, H.; Yashiki, T.; Shimamoto, T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid and copoly(lactic/glycolic) acid. Bull. Chem. Pharm. 1985, 36, 1095-1103.
16. Johnson, O. L.; Cleland, J. L.; Lee, H. J.; Charmis, M.; Duenas, E.; Jaworowicz, W.; Shepard, D.; Shahzamani, A.; Jones A. J. S.; Putney, S. D. A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med. 1996, 3, 795-799.
17. Edelman, E.; Brown, L.; Langer, R. In-vitro and in vivo kinetics of regulated drug release from polymer matrices by oscillating magnetic fields. J. Biomed. Mater. Sci. 1978, 21, 339-353.
18. Edelman, E.; Kost, J.; Bobeck, H.; Langer, R. Regulation of drug release from porous polymer matrices by oscillating magnetic fields. J. Biomed. Mater. Res. 1985, 19, 67-83.
19. Kost, J.; Wolfrum, J.; Langer, R. Magnetically controlled insulin release in diabetic rats. J. Biomed. Res. 1987, 21, 1367-1373.
20. Santini, J. T., Jr.; Cima, M. J.; Langer, R. A controlled release microchip. Nature 1999, 397, 335-338.
21. Kwon, I. C.; Bae, Y. H.; Kim, S. W. Electrically erodible polymer gel for controlled release of drugs. Nature 1991, 354, 291-293.
22. Siegel, R. A.; Falamarzian, M.; Firestone, B. A.; Moxley, B. C. pH-controlled release from hydrophobic/polyelectrolyte copolymer hydrogels. J. Controlled Release 1988, 8, 179-182.
23. Hoffman, A. S.; Afrassiabi, A.; Doug, L. C. Thermally reversible hydrogels: II. delivery and selective removal of substances from aqueous solutions. J. Controlled Release 1986, 4, 213-222.
24. Heller, J. Feedback-controlled drug delivery. In Controlled drug delivery: challenges and strategies; Park, K., Ed.; American Chemical Society: Washington, DC, 1997; pp 127-146.
25. Peppas, N. A. Hydrogels and drug delivery. Curr. Opin. Colloid Interface Sci. 1997, 2, 531-537.
26. Peppas, N. A.; Langer, R. New challenges in biomaterials. Science 1994, 263, 1715-1720.
27. Domb, A.; Langer, R. Polyanhydrides: I. preparation of high molecular weight polyanhydrides. J. Polym. Sci. 1987, 25, 3373-3386.
28. Leong, K. W.; Brott, B. C.; Langer, R. Bioerodible polyanhydrides as drug-carrier matrices: I. characterization, degradation and release characteristics. J. Biomed. Mater. Res. 1985, 19, 941-955.
29. Leong, K. W.; D'Amore, P.; Marletta, M.; Langer, R. Bioerodible polyanhydrides as drug-carrier matrices: II: biocompatibility and chemical reactivity. J. Biomed. Mater. Res. 1986, 20, 51-64.
30. Laurencin, C.; Domb, A.; Morris, C.; Brown, V.; Chasin, M.; McConnell, R.; Lange, N.; Langer, R. Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. J. Biomed. Mater. Res. 1990, 24 (11), 1463-1481.
31. Brem, H.; Kader, A.; Epstein, J. I.; Tamargo, R. J.; Domb, A.; Langer, R., Leong, K. W. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. Sel. Cancer Ther. 1989, 5, 55-65.
32. Brem, H.; Ahn, H.; Tamargo, R. J.; Domb, A.; Langer, R.; Leong, K. W. A biodegradable polymer for intracranial drug delivery: A radiological study in primates. Am. Assoc. Neurol. Surg. 1993, 39 (1), 2-7.
33. Brem, H.; Mahaley, S.; Vick, N. A.; Black, K. L.; Schold, C.; Burger, P. C., Friedman A. H.; Ciric I. S.; Eller T. W.; Cozzens J. W.; Kenealy J. N. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg. 1991, 74, 441-446.
34. Brem, H.; Piantidosi, S.; Burger, P. C.; Walker, M.; Mohr, G.; Muller, P.; Morawetz, R.; Schold, S. C. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery of biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995, 345, 1008-1012.
35. Valtonen, S.; Timonen, U.; Toivanen, P.; Kalimo, H.; Kivipelto, L.; Heiskanen, O.; Unsgaard, G.; Kuurne, T. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 1997, 41, 44-49.
36. Jacobs, M. Conventional Wisdom. Chem. Eng. News 1996, 74 (42), 5.
37. Delgado-Charro, M. B.; Guy, R. Percutaneous penetration and transdermal drug delivery. Dermatology Foundation 1998, 32 (4), 1-12.
38. Henningfield, J. E. Nicotine medications for smoking cessation. New Engl. J. Med. 1995, 333, 1196-1203.
39. Kost, J.; Leong, K.; Langer, R. Effects of Ultrasound on Polymer Degradation and Release of Incorporated Substances. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 7663-7666.
40. Levy, D.; Kost, J.; Meshulam, Y.; Langer, R., Effect of Ultrasound on Transdermal Drug Delivery to Rats and Guinea Pigs. J. Clin. Invest. 1989, 83, 2074-2078.
41. Bommannan, D.; Menon, G. K.; Okuyama, H.; Elias, P. M.; Guy, R. H. Sonophoresis. II. Examination of the Mechanism(s) of Ultrasound-Enhanced Transdermal Drug Delivery. Pharm. Res. 1992, 9, 1043-1047.
42. Bommannan, D.; Okuyama, H.; Stauffer, P.; Guy, R. H. Sonophoresis. I. The Use of Hugh-Frequency Ultrasound to Enhance Transdermal Drug Delivery. Pharm. Res. 1992, 9, 559-564.
43. Mitzaki, S.; Mizuoka, O.; Takada, M. External Control of Drug Release and Penetration: Enhancement of the Transdermal Absorption of Indomethacin by Ultrasound Irradiation. J. Pharm. Pharmacol. 1990, 43, 115-116.
44. Tachibana, K. Transdermal Delivery of Insulin to Alloxan-Diabetic Rabbits by Ultrasound Exposure. Pharm. Res. 1992, 9, 952-954.
45. Mitragotri, S.; Edwards, D.; Blankschtein, D.; Langer, R. A Mechanistic Study of Ultrasonically Enhanced Transdermal Drug Delivery, J. Pharm. Sci. 1995, 84, 697-706.
46. Mitragotri, S.; Blankschtein, D.; Langer, R. Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res. 1996, 13, 411-420.
47. Mitragotri, S.; Blankschtein, D.; Langer, R. Ultrasound-mediated transdermal protein delivery. Science 1995, 269, 850-853.
48. Kost, J.; Mitragotri, S.; Gabbay, R. A.; Pishko, M.; Langer, R. Ultrasound for non-invasive monitoring of glucose and other analytes. Nature Med. In press.
49. Niven, R. W. Delivery of biotherapeutics by inhalation aerosol. Crit. Rev. Therap. Drug Carrier Syst. 1995, 12, 151-231.
50. Patton, J. S. Mechanisms of macromolecule absorption by the lungs. Adv. Drug Deliv. Rev. 1996, 19, 3-36.
51. Schuster, J.; Rubsamen, R.; Lloyd, P.; Lloyd, J. The AERx aerosol delivery system. Pharm. Res. 1997, 14, 354-357.
52. Edwards, D. A.; Hanes, J.; Caponetti, G.; Hrkach, J.; Ben-Jebria, A.; Eskew, M. L.; Mintzes, J.; Deaver, D.; Lotan, N.; Langer, R. Large porous aerosols for pulmonary drug delivery. Science 1997, 276, 1868-1871.
53. Langer, R.; Vacanti, J. Tissue Engineering. Science 1993, 260, 920-926.
54. Langer, R.; Vacanti, J. Artificial Organs. Sci. Am. 1995, 273, 100-103.
55. Folkman, J.; Haudenschild, C. Angiogenesis in vitro. Nature 1980, 288, 855-860.
56. Bissell, M. J.; Barcellos-Hoff, M. H. The Influence of Extracellular Matrix on Gene Expression: Is Structure the Message? J. Cell. Sci., Suppl. 1987, 8, 327-343.
57. Vacanti, J.; Morse, M. A.; Saltzman, W. M.; Domb, A. J.; Perez-Atayde, A.; Langer, R. Selective Cell Transplantation Using Bioabsorbale Artificial Polymers as matrices. J. Ped. Surg. 1988, 23, 3-9.
58. Cima, L. G.; Vacanti, J. P.; Vacanti, C.; Ingber, D.; Mooney, D.; Langer, R. Tissue Engineering by Cell Transplanation Using Degradable Polymer Substrates. J. Biomed. Eng. 1991, 113, 143-151.
59. Barrera, D. A.; Zylstra, E.; Lansbury, P. T.; Langer, R. Synthesis and RGD Peptide Modification of a New Biodegradable Copolymer System: Poly(Lactic Acid-co-Lysine). J. Am. Chem. Soc. 1993, 115, 11010-11011.
60. Cook, A. D.; Hrkach, J. S.; Gao, N. N.; Johnson, I. M.; Pajvani, U. B.; Cannizzaro, S. M.; Langer, R. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J. Biomed. Mater. Res. 1997, 35, 513-523.
61. Mooney, D. J.; Park, S.; Kaumann, P. M.; Sano, K.; McNamara, K.; Vacanti, J. P.; Langer, R. Biodegradable sponges for hepatocyte transplantation. J. Biomed. Mater. Res. 1994, 29, 959-966.
62. Mikos, A.; Bao, Y.; Ingber, D. E.; Vacanti, J. P.; Langer, R. Preparation of polylglycolic acid) bonded fiber structures for cell transplantation. J. Biomed. Med. Res. 1993, 27, 183-189.
63. Freed, L.; Vunjak-Novakovic, G.; Biron, R.; Eagles, D.; Lesnoy, D.; Barlow, S.; Langer, R. Biodegradable Polymer Scaffolds for Tissue Engineering. Bio/Technology 1994, 12, 689-693.
64. Vunjak-Novakovic, G.; Obradovic, B.; Martin, I.; Bursac, P.; Langer, R. Dynamic Cell Seeding of Polymer Scaffolds for Cartilage Tissue Engineering. Biotechnol. Progress 1998, 14, 193-202.
65. Vacanti, C.; Langer, R.; Schloo, B.; Vacanti, J. P. Synthetic Polymers Seeded with Chondrocytes Provide a Template for New Cartilage Formation. J. Plastic Surg. 1991, 88, 753-759.
66. Langer, R.; Vunjak, G.; Freed, L.; Atala, A.; Vacanti, C.; Vacanti, J. Tissue Engineering: Biomedical Applications. Tissue Eng. 1995, 1, 151-162.
67. Vacanti, J.; Langer, R. Tissue Engineering. Lancet 1999, 354, 32-34.
68. Niklason, L. E.; Gao, J.; Abbot, W. M.; Hirschi, K.; Houser, S.; Marini, R.; Langer, R. Functional arteries grown in vitro. Science 1999, 284, 489-493.
69. Zund, G.; Breuer, C.; Shinoka, T.; Ma, P.; Langer, R.; Mayer J.; Vacanti, J. P. A novel approach for construction of a bioprosthetic heart valve. Eur. J. Cardio-thoracic Surg. 1997, 11, 493-497.
70. Schmidt, C. E.; Shastri, V. R.; Vacanti, J. P.; Langer, R. Stimulation of neurite outgrowth using an electrically conducting polymer, Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 8948-8953.
71. Hansbrough, J. F.; Dore, R. N.; Hansbrough, W. Clinical Trials of a Living Dermal Tissue Replacement Placed beneath Meshed, Split-Thickness Skin Grafts on Excised Burn Wounds. J. Burn Care Rehab. 1992, 13, 519-529.